Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Articles
BioCentury
|
Mar 16, 2009
Company News
Genavia Therapeutics Ltd., Origen Therapeutics Inc., Symphogen deal
...will receive an undisclosed equity stake in Genavia and is eligible for milestones and royalties.
Genavia Therapeutics Ltd.
...
Read More
Items per page:
10
1 - 1 of 1
BioCentury
|
Mar 16, 2009
Company News
Genavia Therapeutics Ltd., Origen Therapeutics Inc., Symphogen deal
...will receive an undisclosed equity stake in Genavia and is eligible for milestones and royalties.
Genavia Therapeutics Ltd.
...
Read More
Items per page:
10
1 - 1 of 1
Previous page
Next page